Fund+

Established in 2015, Fund+ is a Belgium-based venture capital firm specializing in life sciences investments. The firm focuses on companies in diagnostics, therapeutics, medical devices, and life sciences sectors, typically investing in Series A and Series B rounds. Their mission is to create sustainable shareholder value, contribute to the life sciences sector's leadership, and generate societal impact.

Notable portfolio companies include iTeos Therapeutics. Key decision-makers at Fund+ have significant industry experience. The firm's investment philosophy centers on fostering innovation in life sciences. Unique value-add services offered include long-term equity investment and strategic support for innovative life sciences companies, particularly those based in Belgium.